ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $261,000 | -5.1% | 56,920 | -13.0% | 0.17% | -3.9% |
Q1 2017 | $275,000 | -20.5% | 65,420 | -21.8% | 0.18% | +27.9% |
Q4 2016 | $346,000 | -95.6% | 83,680 | -91.3% | 0.14% | -94.6% |
Q3 2016 | $7,798,000 | +16.8% | 962,810 | +12.5% | 2.58% | +23.3% |
Q2 2016 | $6,674,000 | +0.6% | 855,570 | -0.5% | 2.09% | +16.4% |
Q1 2016 | $6,636,000 | -32.5% | 859,560 | -5.6% | 1.80% | -11.6% |
Q4 2015 | $9,830,000 | +31.0% | 911,010 | -16.1% | 2.03% | +34.0% |
Q3 2015 | $7,504,000 | +53.4% | 1,086,000 | +96.8% | 1.52% | +69.6% |
Q2 2015 | $4,891,000 | +1113.6% | 551,960 | +1576.2% | 0.90% | +1764.6% |
Q4 2014 | $403,000 | – | 32,930 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |